Ajanta Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-five approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
| US Patents: | 0 |
| Tradenames: | 55 |
| Ingredients: | 54 |
| NDAs: | 65 |
| Drug Master File Entries: | 2 |
Drugs and US Patents for Ajanta Pharma Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | OXCARBAZEPINE | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 217659-003 | Feb 22, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ajanta Pharma Ltd | RISPERIDONE | risperidone | TABLET;ORAL | 201003-004 | Aug 24, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ajanta Pharma Ltd | CAPTOPRIL | captopril | TABLET;ORAL | 212809-002 | Dec 13, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ajanta Pharma Ltd | TOPIRAMATE | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 215663-001 | Aug 15, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ajanta Pharma Ltd | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 204320-002 | May 30, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
